I know pyrr and his voices will mock me, but yes, I have long held the belief that approval and manufacturing capacity should be well timed if DCVax-l has strong results. I don't have the best memory, but I think this was one of the first messages I ever anonymously sent to nwbo. As an investor, it's frustrating now, but my former self had unbiased intentions. Anyway, nothing I say was not already is discussed by NWBO long before I thought of it.
The point is, in the best possible scenario, manufacturing capacity that can respond to high demand is essential for both equality and a successful launch.
News 
Market Data 
Discover 
AI
